drugset / Trial / NCT00815100

Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome

NCT00815100

Phase 4 Completed 27 enrolled Hospital Universitario de Canarias
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate whether a pure heart rate-lowering agent (Ivabradine) reduces vascular inflammatory stress in patients with acute coronary syndromes

Timeline

Start
2009-04
Primary completion
2011-04
Completion
2011-09-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ivabradine Small molecule 7.5 mg